April 21, 2015
Entasis Therapeutics has retained The Chase Group to secure a Chief Medical Officer responsible for the overall direction, planning, execution and interpretation of medical affairs, regulatory affairs and clinical research programs implemented by the company. He/she will 1) oversee the development and conduct of clinical trials in the U.S. and internationally, as appropriate; 2) provide expertise and experience to the medical affairs, regulatory affairs and clinical operations team through sound management skills; 3) communicate department goals cross-functionally; 4) oversee budgets; 5) proactively identify problems and facilitate team solutions; and 6) ensure GCP standards, regulatory standards and FDA compliance. For more information, contact Joyce Tucker at 913.663.3100 or joyce@chasegroup.com.
